Core Viewpoint - Tianyi Medical (301097) experienced a decline in stock price, closing at 64.03 yuan on November 13, 2025, down 1.94% with a trading volume of 45,300 lots and a turnover of 284 million yuan [1] Group 1: Financial Performance - For the first three quarters of 2025, Tianyi Medical reported a main business revenue of 387 million yuan, an increase of 24.14% year-on-year [5] - The net profit attributable to shareholders was 20.09 million yuan, up 216.81% year-on-year [5] - The third quarter alone saw a main business revenue of 160 million yuan, a year-on-year increase of 48.03%, with a net profit of 10.61 million yuan, up 227.86% year-on-year [5] - The company reported a gross profit margin of 38.39% and a net profit margin of 5.4% [5] Group 2: Market Activity - On November 13, 2025, the net outflow of main funds was 20.40 million yuan, accounting for 7.2% of the total turnover, while retail investors saw a net inflow of 7.60 million yuan, representing 2.68% of the total turnover [1][2] - The financing data indicated a net purchase of 9.05 million yuan on the same day, with a financing balance of 60.77 million yuan [3] Group 3: Industry Comparison - Tianyi Medical's total market value is 3.727 billion yuan, significantly lower than the industry average of 11.668 billion yuan, ranking 94 out of 124 in the medical device sector [5] - The company's price-to-earnings ratio stands at 139.09, compared to the industry average of 59.01, ranking 76 out of 124 [5] - The net asset value is 1.182 billion yuan, while the industry average is 3.893 billion yuan, placing Tianyi Medical at 102 out of 124 [5]
天益医疗（301097）11月13日主力资金净卖出2040.35万元